BeStock  
Stocks › Biotechnology › PRME

Prime Medicine PRME

US equityMarket cap rank #3316Biotechnology
$3.55 −$0.29 (-7.55%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $3.56 +0.28%
Open$3.70
Prev close$3.84
Day range$3.49 – $3.94
Volume6.13M
Market cap$791.62M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.4x
CheapRich

Below its usual level · 29th percentile, 5-year average -5.6x

Price / book112.4x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 4.5x

#5298 of 5328 stocks by PB (1 = cheapest)

Price / sales134.5x
CheapRich

Above its usual level · 60th percentile, 5-year average 216.2x

#4979 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-51x-32x-12x7xOct '22Oct '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$9.24
Price vs. fair value-61.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 112.37 – 4.46 100% (pricier than usual) #5298 of 5328 (1 = cheapest)
PE -4.40 -4.83 -5.63 29% (cheaper than usual) –
PS 134.52 91.61 216.20 60% (pricier than usual) #4979 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on PRME.

Sign in to join the discussion.

Scroll to Top